266 related articles for article (PubMed ID: 19956156)
1. The size of the prize for earlier diagnosis of cancer in England.
Richards MA
Br J Cancer; 2009 Dec; 101 Suppl 2(Suppl 2):S125-9. PubMed ID: 19956156
[TBL] [Abstract][Full Text] [Related]
2. Stage at diagnosis and early mortality from cancer in England.
McPhail S; Johnson S; Greenberg D; Peake M; Rous B
Br J Cancer; 2015 Mar; 112 Suppl 1(Suppl 1):S108-15. PubMed ID: 25734389
[TBL] [Abstract][Full Text] [Related]
3. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.
Coleman MP; Forman D; Bryant H; Butler J; Rachet B; Maringe C; Nur U; Tracey E; Coory M; Hatcher J; McGahan CE; Turner D; Marrett L; Gjerstorff ML; Johannesen TB; Adolfsson J; Lambe M; Lawrence G; Meechan D; Morris EJ; Middleton R; Steward J; Richards MA;
Lancet; 2011 Jan; 377(9760):127-38. PubMed ID: 21183212
[TBL] [Abstract][Full Text] [Related]
4. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.
Maringe C; Spicer J; Morris M; Purushotham A; Nolte E; Sullivan R; Rachet B; Aggarwal A
Lancet Oncol; 2020 Aug; 21(8):1023-1034. PubMed ID: 32702310
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic intervals and its association with breast, prostate, lung and colorectal cancer survival in England: historical cohort study using the Clinical Practice Research Datalink.
Redaniel MT; Martin RM; Ridd MJ; Wade J; Jeffreys M
PLoS One; 2015; 10(5):e0126608. PubMed ID: 25933397
[TBL] [Abstract][Full Text] [Related]
6. The National Awareness and Early Diagnosis Initiative in England: assembling the evidence.
Richards MA
Br J Cancer; 2009 Dec; 101 Suppl 2(Suppl 2):S1-4. PubMed ID: 19956152
[TBL] [Abstract][Full Text] [Related]
7. Emergency presentation of cancer and short-term mortality.
McPhail S; Elliss-Brookes L; Shelton J; Ives A; Greenslade M; Vernon S; Morris EJ; Richards M
Br J Cancer; 2013 Oct; 109(8):2027-34. PubMed ID: 24045658
[TBL] [Abstract][Full Text] [Related]
8. Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results?
Thomson CS; Forman D
Br J Cancer; 2009 Dec; 101 Suppl 2(Suppl 2):S102-9. PubMed ID: 19956153
[TBL] [Abstract][Full Text] [Related]
9. An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementation.
Weller D; Vedsted P; Anandan C; Zalounina A; Fourkala EO; Desai R; Liston W; Jensen H; Barisic A; Gavin A; Grunfeld E; Lambe M; Law RJ; Malmberg M; Neal RD; Kalsi J; Turner D; White V; Bomb M; Menon U;
BMJ Open; 2016 Jul; 6(7):e009641. PubMed ID: 27456325
[TBL] [Abstract][Full Text] [Related]
10. Late metastatic presentation is associated with improved survival and delayed wide-spread progression after ablative stereotactic body radiotherapy for oligometastasis.
Chen X; Chen H; Poon I; Erler D; Badellino S; Biswas T; Dagan R; Foote M; Louie AV; Ricardi U; Sahgal A; Redmond KJ
Cancer Med; 2021 Sep; 10(18):6189-6198. PubMed ID: 34432390
[TBL] [Abstract][Full Text] [Related]
11. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care.
Tørring ML; Frydenberg M; Hansen RP; Olesen F; Vedsted P
Eur J Cancer; 2013 Jun; 49(9):2187-98. PubMed ID: 23453935
[TBL] [Abstract][Full Text] [Related]
12. Travel times to health care and survival from cancers in Northern England.
Jones AP; Haynes R; Sauerzapf V; Crawford SM; Zhao H; Forman D
Eur J Cancer; 2008 Jan; 44(2):269-74. PubMed ID: 17888651
[TBL] [Abstract][Full Text] [Related]
13. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
14. Preferences for cancer investigation: a vignette-based study of primary-care attendees.
Banks J; Hollinghurst S; Bigwood L; Peters TJ; Walter FM; Hamilton W
Lancet Oncol; 2014 Feb; 15(2):232-40. PubMed ID: 24433682
[TBL] [Abstract][Full Text] [Related]
15. Would compliance with cancer care standards improve survival for breast, colorectal and lung cancers?
McCarthy M; Datta P; Khachatryan A; Coleman MP; Rachet B
J Epidemiol Community Health; 2008 Jul; 62(7):650-4. PubMed ID: 18559449
[TBL] [Abstract][Full Text] [Related]
16. Mortality from all cancers and lung, colorectal, breast and prostate cancer by country of birth in England and Wales, 2001-2003.
Wild SH; Fischbacher CM; Brock A; Griffiths C; Bhopal R
Br J Cancer; 2006 Apr; 94(7):1079-85. PubMed ID: 16523198
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer screening in England and the United States: a comparison of provision and utilisation.
Williams J; Garvican L; Tosteson AN; Goodman DC; Onega T
Int J Public Health; 2015 Dec; 60(8):881-90. PubMed ID: 26446081
[TBL] [Abstract][Full Text] [Related]
18. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924
[TBL] [Abstract][Full Text] [Related]
19. A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004.
Morris EJ; Sandin F; Lambert PC; Bray F; Klint A; Linklater K; Robinson D; Påhlman L; Holmberg L; Møller H
Gut; 2011 Aug; 60(8):1087-93. PubMed ID: 21303917
[TBL] [Abstract][Full Text] [Related]
20. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study.
Clegg LX; Li FP; Hankey BF; Chu K; Edwards BK
Arch Intern Med; 2002 Sep; 162(17):1985-93. PubMed ID: 12230422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
